Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Barbieri

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Pathology|June 5, 2013
Re: Stoehr et al. Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453-456Christopher E Barbieri, Andrea Sboner, Mark A Rubin, et al.
The Journal of Urology|July 14, 2020
Active Surveillance for Men with Intermediate Risk Prostate CancerVishesh Agrawal, Xiaoyue Ma, Jim C Hu, et al.
Advances in Radiation Oncology|July 11, 2022
Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation TherapyVishesh Agrawal, Xiaoyue Ma, Jim C Hu, et al.
Cancer Research|August 4, 2006
Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasisChristopher E Barbieri, Luo Jia Tang, Kimberly A Brown, et al.
European Urology|February 5, 2019
Unraveling Prostate Cancer Genomics, Pathology, and Magnetic Resonance Imaging VisibilityJonathan E Shoag, Jeffrey J Tosoian, Simpa S Salami, et al.
JAMA Network Open|September 1, 2020
Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the USVishesh Agrawal, Xiaoyue Ma, Jim C Hu, et al.
The Journal of Urology|January 27, 2021
Understanding the True Prevalence of Prostate Cancer Genomic Subtypes: Use of Inverse Probability Weighting to Correct for Biases in Molecularly Profiled CohortsPeter Y Cai, Xiaoyue Ma, Paul Christos, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 6, 2021
Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer under Active Surveillance: Cancer Prostate Embolization, a Pilot StudyAdithya Balasubramanian, Himanshu Nagar, Christopher E Barbieri, et al.
Cell Cycle (Georgetown, Tex.)|April 23, 2005
Ultraviolet radiation induces phosphorylation and ubiquitin-mediated degradation of DeltaNp63alphaMatthew D Westfall, Amanda S Joyner, Christopher E Barbieri, et al.
European Urology|August 28, 2016
The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven TherapeuticsChristopher E Barbieri, Arul M Chinnaiyan, Seth P Lerner, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Pathology|June 5, 2013
Re: Stoehr et al. Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453-456Christopher E Barbieri, Andrea Sboner, Mark A Rubin, et al.
The Journal of Urology|July 14, 2020
Active Surveillance for Men with Intermediate Risk Prostate CancerVishesh Agrawal, Xiaoyue Ma, Jim C Hu, et al.
Advances in Radiation Oncology|July 11, 2022
Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation TherapyVishesh Agrawal, Xiaoyue Ma, Jim C Hu, et al.
Cancer Research|August 4, 2006
Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasisChristopher E Barbieri, Luo Jia Tang, Kimberly A Brown, et al.
European Urology|February 5, 2019
Unraveling Prostate Cancer Genomics, Pathology, and Magnetic Resonance Imaging VisibilityJonathan E Shoag, Jeffrey J Tosoian, Simpa S Salami, et al.
JAMA Network Open|September 1, 2020
Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the USVishesh Agrawal, Xiaoyue Ma, Jim C Hu, et al.
The Journal of Urology|January 27, 2021
Understanding the True Prevalence of Prostate Cancer Genomic Subtypes: Use of Inverse Probability Weighting to Correct for Biases in Molecularly Profiled CohortsPeter Y Cai, Xiaoyue Ma, Paul Christos, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 6, 2021
Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer under Active Surveillance: Cancer Prostate Embolization, a Pilot StudyAdithya Balasubramanian, Himanshu Nagar, Christopher E Barbieri, et al.
Cell Cycle (Georgetown, Tex.)|April 23, 2005
Ultraviolet radiation induces phosphorylation and ubiquitin-mediated degradation of DeltaNp63alphaMatthew D Westfall, Amanda S Joyner, Christopher E Barbieri, et al.
European Urology|August 28, 2016
The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven TherapeuticsChristopher E Barbieri, Arul M Chinnaiyan, Seth P Lerner, et al.
Pageof 11